RxDoctor Payments Data

Michael Baker

Podiatrist · Anderson, INNPI 1750313839

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $3,432 of the $4,874 with a category attached, or 70.4%. 17 manufacturers reported payments, led by Integra Lifesciences Corporation at 26.6% of the total. Reporting peaked in 2023 at $2,451 and has fallen 77.3% since, to $555 in 2025.

$4,874in general payments, 2019–2025

Across 96 payments — averaging $50.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Integra Lifesciences Corporation$1K
  • Medical Device Business Services, Inc.$1K
  • Johnson & Johnson$826
  • Organogenesis Inc.$461
  • Bioventus LLC$257
  • Polynovo North America LLC$199
  • plus $755 from 11 others

What the payments were for

  • Speaking & faculty fees$1243%
  • Travel & lodging$99220%
  • Food & beverage$3,43270%
  • Other$3267%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,874 in reported general payments places this provider in the 70th percentile of 131 podiatrist providers in Indiana.

See all podiatrist providers in Indiana

Medicare billing

Part B allowed, 2024
$118,888
Medicare patients
390
Services billed
2,027

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ciclopirox36$931
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen74$580
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen56$400
Doxycycline Hyclate60$388
Doxycycline Monohydrate11$249
SsdSilver Sulfadiazine18$211
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav33$198
Silver Sulfadiazine25$137
Terbinafine Hcl16$130
Ketoconazole16$79
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim15$76
Meloxicam21$26

Paid to pharmacies, not to this prescriber.

Other podiatrist in Anderson

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →